Literature DB >> 10416606

Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection.

H R Kim1, Y Luo, G Li, D Kessel.   

Abstract

Apoptosis is a cellular death process involving the sequential activation of a series of caspases, endonucleases, and other enzymes. The initiation of apoptosis can be inhibited by overexpression of bcl-2 and certain other members of a related family of proteins. We examined the effects of bcl-2 overexpression on the apoptotic response to photodynamic therapy (PDT), using aluminum phthalocyanine as the photosensitizing agent. In this study, we compared the immortalized human breast epithelial cell line MCF10A with a subline (MCF10A/bcl-2) transfected with the human bcl-2 gene. The latter was approximately 2-fold more sensitive to the phototoxic effects of PDT. At a 50 mJ/cm2 light dose, photodamage to MCF-10A/bcl-2 resulted in a greater loss of the mitochondrial membrane potential (delta(psi)m), enhanced release of mitochondrial cytochrome c, a more rapid and greater activation of caspase-3, and a greater apoptotic response. Western blot analysis revealed that the transfected cell line showed overexpression of both bcl-2 and bax, and that PDT caused selective destruction of bcl-2, leaving bax unaffected. The greater apoptotic response by the transfected line is, therefore, attributed to the higher bax:bcl-2 ratio after photodamage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416606      PMCID: PMC4564253     

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2.

Authors:  J He; M L Agarwal; H E Larkin; L R Friedman; L Y Xue; N L Oleinick
Journal:  Photochem Photobiol       Date:  1996-11       Impact factor: 3.421

2.  Inhibition of Bax channel-forming activity by Bcl-2.

Authors:  B Antonsson; F Conti; A Ciavatta; S Montessuit; S Lewis; I Martinou; L Bernasconi; A Bernard; J J Mermod; G Mazzei; K Maundrell; F Gambale; R Sadoul; J C Martinou
Journal:  Science       Date:  1997-07-18       Impact factor: 47.728

3.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

4.  Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c.

Authors:  T Rossé; R Olivier; L Monney; M Rager; S Conus; I Fellay; B Jansen; C Borner
Journal:  Nature       Date:  1998-01-29       Impact factor: 49.962

5.  Bax directly induces release of cytochrome c from isolated mitochondria.

Authors:  J M Jürgensmeier; Z Xie; Q Deveraux; L Ellerby; D Bredesen; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

6.  Use of a tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro.

Authors:  A P McHale; L McHale
Journal:  Cancer Lett       Date:  1988-08-30       Impact factor: 8.679

7.  bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells.

Authors:  S Upadhyay; G Li; H Liu; Y Q Chen; F H Sarkar; H R Kim
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

8.  Conversion of Bcl-2 to a Bax-like death effector by caspases.

Authors:  E H Cheng; D G Kirsch; R J Clem; R Ravi; M B Kastan; A Bedi; K Ueno; J M Hardwick
Journal:  Science       Date:  1997-12-12       Impact factor: 47.728

9.  Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

Authors:  P Li; D Nijhawan; I Budihardjo; S M Srinivasula; M Ahmad; E S Alnemri; X Wang
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

10.  Overexpression of the Bcl-2 protein increases the half-life of p21Bax.

Authors:  T Miyashita; S Kitada; S Krajewski; W A Horne; D Delia; J C Reed
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

View more
  43 in total

Review 1.  Autophagic death probed by photodynamic therapy.

Authors:  David Kessel
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

2.  Light-Activated Pharmaceuticals: Mechanisms and Detection.

Authors:  David Kessel; John Reiners
Journal:  Isr J Chem       Date:  2012-09-01       Impact factor: 3.333

3.  Adventures in photodynamic therapy: 1976-2008.

Authors:  David Kessel
Journal:  J Porphyr Phthalocyanines       Date:  2008-07-24       Impact factor: 1.811

4.  Initiation of apoptosis and autophagy by photodynamic therapy.

Authors:  David Kessel; M Graça H Vicente; John J Reiners
Journal:  Lasers Surg Med       Date:  2006-06       Impact factor: 4.025

5.  Apoptotic and autophagic responses to Bcl-2 inhibition and photodamage.

Authors:  David Kessel; Adelaida Segarra Arroyo
Journal:  Photochem Photobiol Sci       Date:  2007-07-30       Impact factor: 3.982

6.  Promotion of PDT efficacy by a Bcl-2 antagonist.

Authors:  David Kessel
Journal:  Photochem Photobiol       Date:  2007-12-20       Impact factor: 3.421

Review 7.  Apoptosis, Paraptosis and Autophagy: Death and Survival Pathways Associated with Photodynamic Therapy.

Authors:  David Kessel
Journal:  Photochem Photobiol       Date:  2018-07-17       Impact factor: 3.421

8.  Death pathways associated with photodynamic therapy.

Authors:  David Kessel
Journal:  Med Laser Appl       Date:  2006-11-15

9.  Photodynamic therapy: Promotion of efficacy by a sequential protocol.

Authors:  David Kessel
Journal:  J Porphyr Phthalocyanines       Date:  2016 Jan-Apr       Impact factor: 1.811

10.  PCNA damage caused by antineoplastic drugs.

Authors:  Soo In Bae; Ran Zhao; Robert M Snapka
Journal:  Biochem Pharmacol       Date:  2008-09-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.